Website News and Research

RSS

Orexigen Therapeutics praises new research report on obesity prevention policies

Orexigen commends CEO as well as the author of the report, Alex Brill , and the Robert Wood Johnson Foundation (RWJF) who funded the report, for this new research illustrating the importance of long-term budget impact analyses on preventive health policies, specifically those aimed at obesity.

26 Apr 2013

Rexceptor receives exclusive license for novel treatment of Alzheimer's disease

Case Western Reserve's Technology Transfer Office has granted an exclusive license of a novel Alzheimer's Disease (AD) treatment strategy to spinoff company ReXceptor Inc., which plans to initiate early-stage human clinical trials of the medication within the next few months.

26 Apr 2013

Universal Health Services net revenues increase 2% to $1.83 billion in first quarter 2013

Universal Health Services, Inc. announced today that its reported net income attributable to UHS was $119.8 million, or $1.21 per diluted share, during the first quarter of 2013 as compared to $128.6 million, or $1.31 per diluted share, during the comparable quarter of 2012.

26 Apr 2013

Molina Healthcare reports strong quarterly results for 2013

Molina Healthcare, Inc. today reported its financial results for the quarter ended March 31, 2013.

26 Apr 2013

Mayo Clinic implements electronic warning system to identify patients at risk of QT-related deaths

Using a one-of-a-kind computer-aided program, Mayo Clinic has developed and implemented a Mayo-wide electronic warning system to identify patients at risk of QT-related deaths from an abnormality in the heart's electrical system.

26 Apr 2013

Dyax reports Q1 2013 financial results; LFRP portfolio continues to be a growth driver

Dyax Corp. today announced financial results for the first quarter ended March 31, 2013. The Company will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and updates regarding its key value drivers - the KALBITOR® (ecallantide) business, the broader angioedema portfolio and the Licensing and Funded Research Program (LFRP).

26 Apr 2013

Cempra reports net loss of $10.3 million in first quarter 2013

Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today reported financial results for the first quarter ended March 31, 2013.

26 Apr 2013

Greatbatch reports 19% increase in adjusted diluted EPS targets for first quarter 2013

Greatbatch, Inc., today announced results for its first quarter ended March 29, 2013 highlighted by a 19% increase in adjusted diluted EPS despite negative 4% constant currency organic revenue growth.

26 Apr 2013

MCCIR scientists use video imaging to investigate effectiveness of rituximab in killing cancerous B cells

Scientists from the Manchester Collaborative Centre for Inflammation Research have discovered why a particular cancer drug is so effective at killing cells.

From The University of Manchester 25 Apr 2013

Roundup: Calif. health care cuts attract opponents; Health law means fewer hours for Va. community college instructors

In the health care world, there's not a whole lot that insurers, doctors and union workers all agree on. But a new coalition of powerful Capitol players from all three groups is hoping to reverse recent budget cuts, pushed by Gov. Jerry Brown, to those who provide care to the poorest Californians.

25 Apr 2013

Opinion pieces address polio eradication goal to be discussed at Global Vaccine Summit

Public and private sector representatives will meet this week in Abu Dhabi at the Global Vaccine Summit, hosted by His Highness General Sheikh Mohamed bin Zayed bin Sultan Al Nahyan, Crown Prince of Abu Dhabi, in partnership with U.N. Secretary-General Ban Ki-moon and Bill Gates, co-chair of the Bill & Melinda Gates Foundation.

24 Apr 2013

Nanogels to attack lupus: an interview with Dr Look and Dr Fahmy, Yale University

Nanogels are synthetic particles that can be used for drug delivery. They are approximately 100 nm to 200 nm in diameter, and are made from safe, biocompatible materials: a gel-like interior and a lipid exterior.

24 Apr 2013

Rheumatoid arthritis diagnosis: an interview with Dr. Stan Naides, Medical Director, Quest Diagnostics

Rheumatoid arthritis (RA) is an autoimmune disorder that can cause debilitating joint damage. In cases of RA, the immune system attacks the body’s own tissues, especially the membranes that line the joints. As a result, fluid builds up in the joints, causing pain and systemic inflammation, leading to joint destruction if untreated.

From Quest Diagnostics 23 Apr 2013

1 in 4 teens misused or abused a prescription drug at least once in their lifetime

New, nationally projectable survey results released today by The Partnership at Drugfree.org and MetLife Foundation confirmed that one in four teens has misused or abused a prescription (Rx) drug at least once in their lifetime - a 33 percent increase over the past five years.

23 Apr 2013

First Edition: April 23, 2013

Today's headlines include reports about immigrant patients' health care as well as the coverage limits that some victims of the Boston Marathon bombings might face.

23 Apr 2013

For states, rejecting the health law's Medicaid expansion comes with consequences

The Associated Press reports on the wrinkles that state leaders will face as a result of opting against the sweeping expansion.

23 Apr 2013

Indoor tanning increases risk of non-melanoma skin cancer

The widespread liking for sunbeds continues to place a huge amount of individuals at risk of developing non-melanoma skin cancer.

22 Apr 2013

New application tool is a user-friendly alternative to previous dietary recall methods

A new website application for athletes called Dietary Analysis Tool for Athletes (D.A.T.A.) has been validated as accurately recording dietary intake based on the 24-hour recall method. "This tool offers sports dietitians and health professionals a new, quick alternative to analyze athletes' dietary intake," said Lindsay Baker, PhD, Principal Scientist, Gatorade Sports Science Institute.

22 Apr 2013

Edible malarial vaccine may work against other viral and bacterial infections

Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That's the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission.

22 Apr 2013

AACN Practice Alert outlines evidence-based protocols related to bathing adult patients

The long-held tradition of using a basin, soap and water to bathe bed-bound hospitalized patients is no longer the recommended standard of practice, according to the American Association of Critical-Care Nurses.

19 Apr 2013

Website News and Research

Orexigen Therapeutics praises new research report on obesity prevention policies

Rexceptor receives exclusive license for novel treatment of Alzheimer's disease

Universal Health Services net revenues increase 2% to $1.83 billion in first quarter 2013

Molina Healthcare reports strong quarterly results for 2013

Mayo Clinic implements electronic warning system to identify patients at risk of QT-related deaths

Dyax reports Q1 2013 financial results; LFRP portfolio continues to be a growth driver

Cempra reports net loss of $10.3 million in first quarter 2013

Greatbatch reports 19% increase in adjusted diluted EPS targets for first quarter 2013

MCCIR scientists use video imaging to investigate effectiveness of rituximab in killing cancerous B cells

Roundup: Calif. health care cuts attract opponents; Health law means fewer hours for Va. community college instructors

Opinion pieces address polio eradication goal to be discussed at Global Vaccine Summit

Nanogels to attack lupus: an interview with Dr Look and Dr Fahmy, Yale University

Rheumatoid arthritis diagnosis: an interview with Dr. Stan Naides, Medical Director, Quest Diagnostics

1 in 4 teens misused or abused a prescription drug at least once in their lifetime

First Edition: April 23, 2013

For states, rejecting the health law's Medicaid expansion comes with consequences

Indoor tanning increases risk of non-melanoma skin cancer

New application tool is a user-friendly alternative to previous dietary recall methods

Edible malarial vaccine may work against other viral and bacterial infections

AACN Practice Alert outlines evidence-based protocols related to bathing adult patients

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News